SAWC Spring 2019 Posters

May 27, 2019Press Releases

Research posters sponsored by Next Science were presented at the Symposium on Advanced Wound Care Spring 2019 meeting in San Antonio, TX.

Next Science Lists on Australian Securities Exchange

April 23, 2019Press Releases

SYDNEY, Australia, 18 April 2019 – Following Next Science Limited’s successful $35 million initial public offer (IPO), the company’s shares are scheduled to list on the ASX at 11.00am today.  The company’s ASX ticker code will be NXS. Read the Full Release

Outliers: Reexamining Wounds That Fail to Heal

January 29, 2019Press Releases

Delayed attention or ineffective treatment nurtures biofilm, facilitating its spread even during bacterial eradication modalities and treatments that involve clinic-based debridement, dressings, antiseptics, and antibiotics. “Could part of the problem be biofilm and part of the healing solution be biofilm-directed care?” This article reexamines why wounds fail to heal. Access the full article, one of … Read More

Next Science® Xbio Technology Expands Use into the Operating Room

October 29, 2018Press Releases

Sydney, NSW and Jacksonville, FL: Next Science® is excited to announce the release of its newest product, SurgX™, available in the US market. SurgX™ is an innovative and first of its type, sterile antimicrobial surgical wound gel designed to help reduce superficial surgical site infections (SSIs) through the management and protection of the post-surgical wound … Read More

Next Science® Expands its Board to Support Continued Global Expansion

October 18, 2018Press Releases

Sydney, NSW: Next Science is excited to announce the appointment of Aileen Stockburger and Mark Compton (AM) to the Board of the company as Non-Executive Directors. Both bring a wealth of diverse international healthcare experience to the Board, as the company expands the adoption of its Xbio™ Technology and the product applications globally across wound … Read More

George Savvides Joins Next Science Board of Directors

August 1, 2018Press Releases

Next Science welcomes George Savvides to its board of directors as Independent Chairperson. Mr Savvides is currently on the board of directors of Ryman Healthcare. He serves as the Chairman of both Macquarie University Hospital and Kings Transport Group Ltd, and is the Deputy Chairman of the Australian public broadcaster, SBS. Read the Full Release

New Mayo Clinic Study Demonstrates Effectiveness of BlastX for Treating Chronic Wounds

February 7, 2018Press Releases

Next Science is excited to announce the results of a prospective, randomized 12-week Mayo Clinic study about the use of BlastX antimicrobial wound gel on chronic wounds to determine if disrupting chronic wound biofilm is therapeutically efficacious. The positive results are published in WOUNDS®. The study represents statistically significant findings for both reduction in wound … Read More

Next Science’s XbioTM Technology Shows Potential to Lower Catheter-Associated Urinary Tract Infection Rates

January 26, 2018Press Releases

Next Science is pleased to announce the publication of a comprehensive article about the application of its Xbio technology to help prevent the development of E. coli biofilms on urinary tract catheters, a leading cause in catheter-associated urinary tract infections. The results are published in the Journal of Medical Microbiology & Diagnosis. View Publication Read … Read More

Judith Mitchell Joins Next Science Board of Directors

November 8, 2017Press Releases

Next Science is proud to announce that Judith Mitchell has been appointed to its board of directors as Director and Chief Executive Officer. Ms. Mitchell joined Next Science in August 2017. Most recently she was President, DePuy Synthes Asia Pacific, the Orthopaedics Division of Johnson & Johnson.

Next Science Showcasing BlastX™ at Fall Wound Care Conferences

October 2, 2017Press Releases

Next Science will highlight its BlastX Antimicrobial Wound Gel at three upcoming conferences. It will exhibit at the Wild on Wounds National Wound Conference in Las Vegas, Nevada, from October 4-7. In addition to exhibiting, it will make poster presentations at SAWC Fall from October 19-22, also in Las Vegas. And Next Science will exhibit … Read More

BlastX™ Highlighted in Consensus Paper on Wound Biofilm

August 14, 2017Press Releases

Next Science’s proprietary BlastX Antimicrobial Wound Gel is highlighted in a recently published consensus paper on biofilm disruption and treatments. The novel Xbio™ technology in BlastX inhibits biofilm development by gram-positive and gram-negative wound pathogens.

Dr. Myntti to Present at Montana State University’s Biofilm Science and Technology Meeting on July 20

July 17, 2017Press Releases

Next Science is pleased to announce that Matthew Myntti, Ph.D., President and Director of R&D will be presenting “Advancing Biofilm Removal via Surgical Wound Lavage” at Montana State University’s Biofilm Science and Technology Meeting on July 20, 2017. Dr. Myntti’s presentation will highlight the collaborative development between Next Science and Zimmer Biomet on their Bactisure™ surgical lavage, an effective solution to the problem of biofilm in healing surgical wounds.

Next Science® Announces Publication of “Wound Biofilm: Current Perspectives and Strategies on Biofilm Disruption and Treatments”

June 28, 2017Press Releases

Leading wound care thought leaders have published a consensus on strategies for biofilm disruption and treatments. The peer-reviewed paper provides a new perspective regarding the need for a paradigm shift toward biofilm treatment strategies and disruption of the bacterial biofilm protective matrix. The publication was supported by Next Science.

Next Science and Zimmer Partner to Launch Bactisure™ Wound Lavage at AAOS

April 19, 2017Press Releases

Next Science and Zimmer Biomet have partnered with an exclusive global sales and distribution agreement for Bactisure™ Wound Lavage, a sterile, aqueous solution used to remove debris—including microorganisms—from wounds using pulsed (jet) lavage. Used as an adjunct to normal saline wound lavage, Bactisure has received FDA 510(k) clearance and is available in 1000mL polypropylene bags with … Read More

Next Science® Irrigation Solution Gains FDA Approval

September 28, 2016Press Releases

Next Science is excited to announce the approval of Next Science Irrigation Solution by the FDA for the irrigation and debridement of wounds. Next Science Irrigation Solution aids in the removal of debris, including microorganisms, from wounds. With broad-range compatibility, Next Science Irrigation Solution is poised to improve the treatment of non-healing wounds and deliver … Read More

Next Science® Acne Gel Shows Positive Results in the Treatment of Acne

July 1, 2016Press Releases

Next Science is excited to release the results of a randomized clinical trial revealing that Next Science Acne Gel was 67% better in improving acne versus the control. “Topical Treatment with an Agent Disruptive to P. acnes Biofilm Provides Positive Therapeutic Response: Results of a Randomized Clinical Trial” appears in the June 2016 issue of Journal of Drugs in Dermatology. The publication was supported by Next Science.

Next Science® Announces Wound Healing Study Results by Dr. Randall Wolcott

September 1, 2015Press Releases

A leading authority in wound care has published the results of a comprehensive study focusing on biofilm disruption and its effects on chronic wound treatment. “Disrupting the biofilm matrix improves wound healing outcomes” appears in the August 2015 issue of Journal of Wound Care. The combination of standard of care plus BlastX™ showed successful treatment for 93% of wounds. This was a 40% increase in healing versus standard of care alone.